‘Acceptability’ of a new oral suspension formulation of mercaptopurine in children with acute lymphoblastic leukaemia

Patient-centred, administration friendly medicines for children – An evaluation of children’s preferences and how they impact medication adherence

(2014) Simon P Bryson   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Regulatory perspectives on acceptability testing of dosage forms in children

(2014) Piotr Kozarewicz   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Demonstrating Evidence of Acceptability: The “Catch-22” of Pediatric Formulation Development

(2013) S Ranmal et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial

(2013) Ajay Vora et al.   LANCET ONCOLOGY

Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

(2012) Smita Bhatia et al.   JOURNAL OF CLINICAL ONCOLOGY

Prescribing for children – taste and palatability affect adherence to antibiotics: a review

(2011) Dave Baguley et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy

(2010) Karla Sánchez-Lara et al.   Nutrition Journal

Drug-Induced Taste Disorders

(2009) Richard L Doty et al.   DRUG SAFETY

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

(2009) A Möricke et al.   LEUKEMIA